logo
Free treatment under Vay Vandana scheme for senior citizens aged 70 and above still elusive in Karnataka

Free treatment under Vay Vandana scheme for senior citizens aged 70 and above still elusive in Karnataka

The Hindu18-06-2025
Free treatment for senior citizens aged 70 and above, under the Ayushman Bharat Vay Vandana (ABVV) scheme, is still elusive in Karnataka. This is because the State's Finance Department has not agreed to the Centre's assurance that the modalities for release of grants for the scheme will be finalised soon.
Responding to the State's letter seeking adequate support to implement the Vay Vandana scheme, which is an extended part of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY), the Centre has requested Karnataka to start providing the services and that the payment modalities for additional cost will be worked out soon.
Sharing ratio
Expressing the State's inability to start the Vay Vandana scheme without any clarity on the fund release, Karnataka's Principal Secretary (Health) Harsh Gupta had written to the Union Health Secretary pointing out that the State is entitled to get ₹36.58 crore from the Centre for the scheme as per the 60:40 sharing ratio of Ayushman Bharat Arogya Karnataka (AB-ArK) scheme.
'Although the sharing ratio for the health scheme between the Centre and State should be 60:40, it is actually 25:75 as the State bears expenditure for around 1.12 crore families while the Centre is only funding the expenses of 69 lakh families as listed under the Socio Economic and Caste Census (SECC) 2011 data,' he said in the letter.
Of the total AB-ArK beneficiaries, the State has around 15.12 lakh families with senior citizens as members. Of these, 9.22 lakh are SECC-identified families (tagged families), and the remaining are over and above the SECC-identified families (untagged families). 'The Centre will provide the State with additional support at the rate of a mere ₹75.7 per family per annum for tagged families and ₹1,052 per family per annum for the untagged families. However, additional support to the untagged families will be provided only after the 69 lakh families out of 1.12 crore total families are tagged,' the letter stated.
NHA's letter
In response to this, L.S. Changsan, Chief Executive Officer of the National Health Authority (NHA) that is the implementing agency for AB PM-JAY, said the additional premium for existing beneficiary families determined at ₹75.7 per family per annum covers the additional top-up wallet of ₹5 lakh, which is utilised only after the primary wallet of the family is exhausted. For new beneficiary families, the annual premium of ₹1,052 per family aligns with the existing premium structure under AB PM-JAY, the NHA CEO's letter stated.
'Based on the consultations with States in July 2024 and the inputs received subsequently, the principles for tagging are being finalised. The identification of existing families and new families will be done based on these principles. However, the State may start providing the services to the Ayushman Vay Vandana card holders and tagging activity will be completed before fund release proposals for the ABVV are due,' the letter said.
No definitive mechanism
However, Karnataka's Finance Department has not agreed to this. 'In the absence of any definite mechanism to link the AB-ArK beneficiaries with the actual SECC data, as per the next best approximation worked out by the State Health Department, Karnataka will require a total of ₹68.98 crore per annum for the senior citizens scheme. As the Centre has to provide 60% of this amount to the State, Karnataka is entitled to get ₹36.58 crore from the Centre. We are now planning to place this issue before the State Cabinet for further discussion,' Mr. Harsh Gupta told The Hindu.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Doctor's Day: Pune doctor leading the critical care revolution
Doctor's Day: Pune doctor leading the critical care revolution

Time of India

time11 hours ago

  • Time of India

Doctor's Day: Pune doctor leading the critical care revolution

Dr. Prashant Sakhavalkar is leading a revolution in advanced critical care and organ transplantation at Dr. D.Y. Patil Medical College, transforming it into a national hub. His team has successfully performed numerous thoracic, liver, and kidney transplants. PUNE: In the elite corridors of Indian medicine, where lung and heart transplants are considered the final frontier—even for the best tertiary care hospitals Dr. Prashant Sakhavalkar and his ICU team is quietly scripting a revolution. As Associate Professor and ICU In-charge has transformed the institution into a national beacon of advanced critical care and thoracic organ transplantation. Under the leadership of Dr. Prashant Sakhvalkar, these complex procedures have consistently delivered outcomes at Dr. D.Y. Patil Medical College, Hospital & Research Centre as 41 thoracic organ transplants, 79 liver transplants, 5 pancreatic transplants, and hundreds of kidney, cornea transplants have been conducted. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune As a seasoned intensivist, he not only leads life-saving procedures but is also a pioneer in ECMO (Extracorporeal Membrane Oxygenation)—a critical support therapy for heart and lung failure. With over 10 years of experience in ECMO, Dr. Sakhavalkar has trained dozens of specialists across the country and is a certified ECMO trainer by the international body ELSO. D.Y. Patil Hospital now runs ELSO-certified ECMO training courses, attracting fellows from across India who come to train under his guidance. Currently, two fellows are undergoing training exclusively in ECMO at the center. As a recognized examiner and academician, Dr. Sakhvalkar plays a pivotal role in mentoring the next generation of intensivist. He is currently spearheading the development of AI-based algorithms for ICU decision-making. Under his guidance, the hospital recently hosted a state-level Tele-ICU conference, exploring how artificial intelligence and telemedicine can extend quality care to even the remotest parts of India. Get the latest lifestyle updates on Times of India, along with Doctor's Day 2025 , messages and quotes!

Silent Epidemic: Shefali Jariwala's Death Sparks Alarm Over Growing Heart Ailments In Young Indians
Silent Epidemic: Shefali Jariwala's Death Sparks Alarm Over Growing Heart Ailments In Young Indians

News18

time2 days ago

  • News18

Silent Epidemic: Shefali Jariwala's Death Sparks Alarm Over Growing Heart Ailments In Young Indians

Last Updated: Data and doctors reveal a deeper and far more widespread crisis: a growing epidemic of cardiovascular disease affecting Indians – not only rich but also poor in far-flung areas. The sudden death of television actress and model Shefali Jariwala, popularly known as the ' Kaanta Laga girl," at the age of 42 due to cardiac arrest has once again stirred public concern over the rising incidence of heart-related ailments in India. While such cases involving young celebrities make headlines, data and doctors reveal a deeper and far more widespread crisis: a growing epidemic of cardiovascular disease affecting Indians – not only rich but also poor in far-flung areas. Heart ailments no more a rich man's disease According to the latest data under the central government's flagship Ayushman Bharat (PM-JAY) scheme, the maximum number of claims are for an angioplasty procedure that involves putting stents in the arteries of the heart to remove blockages, which could prove fatal. The scheme serves as health insurance for the bottom 40 per cent population of India – who are extremely poor and vulnerable, busting the myth that heart ailment is a rich man's disease. The data shows that a whopping Rs 1051 crore has been spent by way of claims under the scheme so far on the procedure named 'PTCA inclusive of diagnostic angiogram'. This is the procedure to perform angioplasty after an angiography is conducted that shows blockages in one's heart. As many as 1.05 lakh patients across the country have undergone this procedure under Ayushman Bharat scheme, implying a spend of Rs 1.05 lakh per patient. In comparison, chronic haemodialysis, though more common with over 15 lakh cases, has led to a lower cumulative spend of Rs 560 crore. The figures clearly indicate that cardiac procedures, though fewer in number, demand significantly higher financial resources — underlining the scale and severity of India's growing heart problem. In fact, several published studies highlight urban versus rural shift of heart ailments. Urban CHD (coronary heart disease) prevalence climbed from roughly 1 per cent in 1960 to 9–10 per cent in 2016 and rural prevalence went from less than 1 per cent to 4–6 per cent, according to a study titled 'Trends in Coronary Heart Disease Epidemiology in India" published in medical journal ScienceDirect. A 9-fold increase in urban CHD over four decades and around 2-fold in rural areas highlights rapid lifestyle transition. 'Five-fold increase in heart procedures" Cardiologists across India are reporting a dramatic surge in cardiac emergencies, especially among young adults. Dr Asit Khanna, Principal Consultant and Director, Cath Lab and Cardiology, Yashoda Super Speciality Hospitals, Kaushambi, told News18, 'The heart-related procedures at my facility have increased 5-fold in 7 years. It was 50 cases in 2018 (when I joined Yashoda), now it's 250 cases per month." Dr Prashant Pawar, Consultant Cardiology at Fortis Hiranandani Hospital, Vashi, also noted a worrying trend. 'Cardiovascular diseases have increased over the past 5 years. On average between 2016-2020, I used to see around 30 to 40 heart attack cases in a month. Over the past 3-4 years I see around 60-70 heart attacks cases in a month. Out of these heart attacks, 30-40 per cent patients are below 40 years and have blood clots (they have more thrombus)," he said. The picture emerging from these accounts is alarming: more young Indians are suffering from heart attacks, and when they do, their condition is often more severe. Supporting this clinical experience is market data from research firm Pharmarack, which confirms that cardiac drugs are now the top-selling segment in India's pharmaceutical market. The segment has grown at a steady 5-year CAGR of 10 per cent, and antihypertensive medications now make up half of all cardiac-related drug sales. What's more concerning is that categories associated with more serious cardiac complications and hospitalisations are growing in double digits. 'Drug sales patterns indicate a disturbing shift in age trends, with cardiac problems increasingly affecting people in the 30–40-year age group, compared to the 50–60-year age bracket in earlier decades," said Sheetal Sapale, vice president, commercial, Pharmarack. The data shows that the sales of heart failure therapies stood at Rs 717 crore in May 2021, which jumped to Rs 1322 crore in May 2025 — almost doubling in four years. India's 'Silent Epidemic' of NCDs The Apollo Hospitals' Health of the Nation 2024 report labels the spike in noncommunicable diseases (NCDs), especially cardiovascular diseases (CVDs), as a 'silent epidemic." According to the report, CVD cases in India jumped from 380 lakh in 2005 to 641 lakh in 2015 — and the number continues to rise. Apollo's annual report 2023-2024 shows that in 2019, lifestyle-linked risks such as unhealthy diet, high blood pressure, high cholesterol, and obesity contributed to 27 per cent of India's total disease burden, compared to 21% in 2010. These risks are directly linked to conditions like ischemic heart disease and stroke. About the Author Himani Chandna Himani Chandna, Associate Editor at CNN News18, specialises in healthcare and pharmaceuticals. With firsthand insights into India's COVID-19 battle, she brings a seasoned perspective. She is particularly More Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! First Published:

Mohalla clinics may become Arogya Mandir's sub-centres
Mohalla clinics may become Arogya Mandir's sub-centres

New Indian Express

time2 days ago

  • New Indian Express

Mohalla clinics may become Arogya Mandir's sub-centres

NEW DELHI: The Delhi government is considering converting Mohalla Clinics operating from porta cabins into sub-centres of Arogya Mandirs, in line with the Centre's Ayushman Bharat Health Infrastructure Mission (AB-HIM), officials privy to the matter said. According to officials, training for staff who will be deployed at these centres is set to begin next month. In April, the Delhi government announced the closure of 250 Aam Aadmi Mohalla Clinics operating from rented premises across the city and the establishment of Arogya Mandirs in nearby locations to replace them. However, for the remaining Mohalla Clinics, converting them into full-fledged Arogya Mandirs appears unfeasible due to space constraints and other operational challenges. 'It was discussed in a meeting held last month, where PWD said shifting Mohalla Clinics in porta cabins would involve significant cost. So, keeping that in mind, there is a proposal to turn them into sub-centres of Arogya Mandirs, where basic primary healthcare services will be provided,' said a government official. Additionally, cancer screening is set to begin in Arogya Mandirs, officials said. 'Medical officers from Arogya Mandirs have been asked to submit a list of staff. Once compiled, they will be trained in cancer screening at a government hospital,' official added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store